Aktie PHARMACYTE BIOTECH INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Pharmacyte Biotech Inc Other OTC

Aktien

US67090R1005

Schlusskurs Other OTC
Andere Börsenplätze
- USD - Intraday Chart für Pharmacyte Biotech Inc
18.03. PharmaCyte Biotech, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Januar 2024 CI
2023 PharmaCyte Biotech, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Oktober 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
PharmaCyte Biotech, Inc. Provides Corporate Update on Cell-In-A-Box Technology
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023
PharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023
PharmaCyte Biotech, Inc. announces an Equity Buyback for 7,750,000 shares, for $25.19 million.
PharmaCyte Biotech, Inc authorizes a Buyback Plan.
PharmaCyte Biotech, Inc. announces an Equity Buyback for $10 million worth of its shares.
PharmaCyte Biotech, Inc. authorizes a Buyback Plan.
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022
PharmaCyte Biotech, Inc. Announces Resignation of Jack E. Stover as Director
PharmaCyte Biotech, Inc. Announces Resignation of Gerald W. Crabtree as Chief Scientific Officer
PharmaCyte Biotech, Inc. Announces Management Changes
PharmaCyte Biotech CEO Kenneth Waggoner Resigns; Board Forms Business Review Committee; Shares Rise
PharmaCyte Biotech, Inc. Announces Management Changes
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022
PharmaCyte Biotech Reaches Agreement With Iroquois to Appoint Two Directors to Board
PharmaCyte Biotech, Inc. Announces Board Appointments
PharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2022
PharmaCyte Biotech Issues a Statement in Response to Iroquois Capital’s Preliminary Consent Statement
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CSPR Aktie
  4. Aktie
  5. Nachrichten Pharmacyte Biotech Inc
  6. Andere Sprachen